Literature DB >> 11914576

HIV vaccine development in the nonhuman primate model of AIDS.

Stephen M Smith1.   

Abstract

Development of a prophylactic human immunodeficiency virus type 1 (HIV-1) vaccine is a leading priority in biomedical research. Much of this work has been done with the nonhuman primate model of AIDS. In a historical context, vaccine studies, which use this model, are summarized and discussed. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914576     DOI: 10.1007/BF02256020

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  5 in total

1.  Mechanisms of Host Resistance Against HIV Infection and Progression to AIDS.

Authors:  Ali A Al-Jabri
Journal:  Sultan Qaboos Univ Med J       Date:  2007-08

2.  HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice.

Authors:  Scott D Parker; Scott T Rottinghaus; Allan J Zajac; Ling Yue; Eric Hunter; Richard J Whitley; Jacqueline N Parker
Journal:  Vaccine       Date:  2007-07-27       Impact factor: 3.641

3.  Human macrophages support persistent transcription from unintegrated HIV-1 DNA.

Authors:  Jeremy Kelly; Margaret H Beddall; Dongyang Yu; Subashini R Iyer; Jon W Marsh; Yuntao Wu
Journal:  Virology       Date:  2007-12-04       Impact factor: 3.616

Review 4.  HIV-1 gene expression: lessons from provirus and non-integrated DNA.

Authors:  Yuntao Wu
Journal:  Retrovirology       Date:  2004-06-25       Impact factor: 4.602

5.  HIV CTL escape: at what cost?

Authors:  Stephen M Smith
Journal:  Retrovirology       Date:  2004-05-12       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.